News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,010 Results
Type
Article (8002)
Company Profile (11)
Press Release (184997)
Section
Business (75862)
Career Advice (449)
Deals (10977)
Drug Delivery (15)
Drug Development (21968)
Employer Resources (52)
FDA (4151)
Job Trends (4047)
News (112297)
Policy (8131)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (2)
2025 Lone Star Bio Digital (1)
Academia (678)
Adcomms (11)
Allergies (24)
Alliances (13033)
ALS (13)
Alzheimer's disease (398)
Antibody-drug conjugate (ADC) (25)
Approvals (4189)
Artificial intelligence (62)
Autoimmune disease (1)
Automation (2)
Bankruptcy (73)
Best Places to Work (3427)
BIOSECURE Act (3)
Biosimilars (16)
Biotechnology (7)
Bladder cancer (13)
Brain cancer (6)
Breast cancer (48)
Cancer (548)
Cardiovascular disease (29)
Career advice (377)
Career pathing (10)
CAR-T (25)
Cell therapy (86)
Cervical cancer (7)
Clinical research (18393)
Collaboration (210)
Compensation (23)
Complete response letters (2)
COVID-19 (504)
CRISPR (11)
C-suite (70)
Cystic fibrosis (18)
Data (547)
Decentralized trials (1)
Denatured (3)
Depression (4)
Diabetes (72)
Diagnostics (1984)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (29)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (11)
Earnings (42370)
Editorial (2)
Employer branding (8)
Employer resources (47)
Events (27033)
Executive appointments (183)
FDA (4412)
Featured Employer (4)
Frontotemporal dementia (3)
Funding (122)
Gene editing (23)
Generative AI (7)
Gene therapy (58)
GLP-1 (114)
Government (951)
Grass and pollen (1)
Guidances (22)
Healthcare (5023)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (11)
Indications (11)
Infectious disease (536)
Inflammatory bowel disease (30)
Influenza (12)
Intellectual property (22)
Interviews (66)
IPO (5595)
IRA (2)
Job creations (800)
Job search strategy (348)
Kidney cancer (7)
Labor market (2)
Layoffs (71)
Leadership (3)
Legal (1493)
Liver cancer (20)
Lung cancer (102)
Lymphoma (38)
Machine learning (1)
Management (19)
Manufacturing (59)
MASH (2)
Medical device (4155)
Medtech (4155)
Mergers & acquisitions (5468)
Metabolic disorders (124)
Multiple sclerosis (18)
Neurodegenerative disease (13)
Neuropsychiatric disorders (2)
Neuroscience (494)
NextGen: Class of 2025 (1584)
Non-profit (1201)
Northern California (528)
Now hiring (2)
Obesity (61)
Opinion (38)
Ovarian cancer (24)
Pain (10)
Pancreatic cancer (17)
Parkinson's disease (42)
Patents (35)
Patient recruitment (24)
Peanut (17)
People (18651)
Pharmaceutical (8)
Phase I (4876)
Phase II (7754)
Phase III (6988)
Pipeline (372)
Podcasts (6)
Policy (9)
Postmarket research (793)
Preclinical (1986)
Press Release (12)
Prostate cancer (25)
Psychedelics (2)
Radiopharmaceuticals (83)
Rare diseases (65)
Real estate (1485)
Recruiting (19)
Regulatory (6175)
Reports (8)
Research institute (639)
Resumes & cover letters (63)
RSV (10)
Schizophrenia (14)
Series A (24)
Series B (16)
Service/supplier (1)
Sickle cell disease (11)
Southern California (542)
Spinal muscular atrophy (28)
Sponsored (6)
Startups (761)
Stomach cancer (4)
Supply chain (11)
The Weekly (3)
United States (5015)
Vaccines (134)
Venture capitalists (5)
Webinars (6)
Weight loss (26)
Women's health (5)
Worklife (5)
Date
Today (46)
Last 7 days (173)
Last 30 days (685)
Last 365 days (8754)
2025 (1899)
2024 (9415)
2023 (11409)
2022 (15131)
2021 (16452)
2020 (15727)
2019 (13595)
2018 (10421)
2017 (10573)
2016 (9581)
2015 (11833)
2014 (8370)
2013 (6483)
2012 (7122)
2011 (7616)
2010 (6677)
Location
Africa (249)
Alabama (6)
Arizona (31)
Arkansas (1)
Asia (14312)
Australia (2602)
California (1255)
Canada (505)
China (189)
Colorado (61)
Connecticut (38)
Delaware (38)
Europe (31127)
Florida (220)
Georgia (46)
Idaho (23)
Illinois (117)
India (6)
Indiana (84)
Iowa (1)
Japan (78)
Kansas (22)
Kentucky (5)
Louisiana (4)
Maine (37)
Maryland (174)
Massachusetts (867)
Michigan (70)
Minnesota (93)
Missouri (16)
Montana (12)
Nebraska (6)
Nevada (18)
New Hampshire (24)
New Jersey (488)
New Mexico (5)
New York (353)
North Carolina (267)
North Dakota (1)
Northern California (528)
Ohio (48)
Oklahoma (3)
Oregon (4)
Pennsylvania (311)
Puerto Rico (4)
Rhode Island (5)
South America (434)
South Carolina (5)
Southern California (542)
Tennessee (18)
Texas (151)
Utah (46)
Virginia (17)
Washington D.C. (10)
Washington State (132)
West Virginia (1)
Wisconsin (13)
193,010 Results for "dermtech international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
DermTech Files for Voluntary Chapter 11 Protection
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware.
June 18, 2024
·
5 min read
Business
DermTech Reports First-Quarter 2024 Financial Results
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, reported its first-quarter 2024 financial results.
May 14, 2024
·
8 min read
Biotech Beach
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
DermTech, Inc. announced that it will discontinue the optional TERT promoter mutation add-on assay for its DermTech Melanoma Test effective March 1, 2024.
January 16, 2024
·
6 min read
Biotech Beach
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive topline results from its Trust 2 Study, which evaluated the foundational gene expression assay component of the DermTech Melanoma Test (DMT) in a real-world clinical setting.
January 8, 2024
·
5 min read
Biotech Beach
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive topline results from a study evaluating the foundational gene expression assay component of the DermTech Melanoma Test (DMT) across all skin types in the real-world clinical setting.
January 18, 2024
·
6 min read
Biotech Beach
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 01, 2024
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, announced that effective March 27, 2024, the Compensation Committee of DermTech’s Board of Directors granted an aggregate of 26,240 restricted stock units to eight new employees under its 2022 Inducement Equity Incentive Plan, as amended, or the 2022 Inducement Plan.
April 1, 2024
·
4 min read
Business
DermTech Reports Fourth-Quarter 2023 Financial Results
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, reported its fourth-quarter 2023 financial results.
February 29, 2024
·
9 min read
Business
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results
DermTech, Inc. will host a conference call and webcast on Thursday, February 29, 2024 at 5:00 p.m. Eastern Time (ET) to discuss the Company’s fourth-quarter 2023 operating and financial results.
February 13, 2024
·
4 min read
Business
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
DermTech, Inc. announced additional restructuring actions to prioritize revenue growth, streamline operations and further reduce overall operating expenses.
January 31, 2024
·
5 min read
Biotech Beach
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentation of two research abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting, taking place March 8th-12th in San Diego, California.
March 8, 2024
·
5 min read
1 of 19,301
Next